Adult Stem Cell Therapy for Premature Ovarian Failure: From Bench to Bedside

卵巢早衰 医学 干细胞 移植 细胞疗法 重编程 肿瘤科 干细胞疗法 内科学 生物信息学 生物 细胞 细胞生物学 遗传学
作者
Mingyao Wang,Yixuan Wang,Jesse Li‐Ling,Huiqi Xie
出处
期刊:Tissue Engineering Part B-reviews [Mary Ann Liebert, Inc.]
卷期号:28 (1): 63-78 被引量:27
标识
DOI:10.1089/ten.teb.2020.0205
摘要

Premature ovarian failure (POF) is a devastating condition for women of childbearing age with serious health consequences, including distress, infertility, osteoporosis, autoimmune disorders, ischemic heart disease, and increased mortality. In addition to the mainstay estrogen therapy, stem cell therapy has been tested as the result of rapid progress in cell biology and reprogramming research. We hereby provide a review for the latest research and issues related with stem cell-based therapy for POF, and provide a commentary on various methods for enhancing its effect. Large amount of animal studies have demonstrated an extensive benefit of stem cells for failed ovarian recovering. As shown by such studies, stem cell therapy can result in recovery of hormonal levels, follicular activation, ovarian angiogenesis, and functional restoration. Meanwhile, a study of molecular pathways revealed that the function of stem cells mainly depends on their paracrine actions, which can produce multiple factors for the promotion of ovarian angiogenesis and regulation of cellular functions. Nevertheless, studies using disease models also revealed certain drawbacks. Clinical trials have shown that menstrual cycle and even pregnancy may occur in POF patients following transplantation of stem cells, although the limitations, including inadequate number of cases and space for the improvement of transplantation methodology. Only with its safety and effect get substantial improvement through laboratory experiments and clinical trials, can stem cell therapy really bring benefits to more patients. Additionally, effective pretreatment and appropriate transplantation methods for stem cells are also required. Taken together, stem cell therapy has shown a great potential for the reversal of POF and is stepping from bench to bedside. Impact statement Premature ovarian failure (POF) is a devastating condition with serious clinical consequences. The purpose of this review was to summarize the current status of stem cell therapy for POF. Considering the diversity of cell types and functions, a rigorous review is required for the guidance for further research into this field. Meanwhile, the challenges and prospect for clinical application of stem cell treatment, methodological improvements, and innovations are addressed.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Loik发布了新的文献求助10
刚刚
充电宝应助绛川采纳,获得10
刚刚
量子星尘发布了新的文献求助10
2秒前
2秒前
CAOHOU应助sue采纳,获得10
3秒前
3秒前
Loik完成签到,获得积分10
6秒前
6秒前
苗条梦玉发布了新的文献求助10
7秒前
7秒前
7秒前
12秒前
绛川发布了新的文献求助10
13秒前
momo发布了新的文献求助10
14秒前
搜集达人应助潘善若采纳,获得10
14秒前
yyer发布了新的文献求助10
15秒前
实心小墩墩完成签到,获得积分10
17秒前
22秒前
23秒前
香蕉觅云应助su采纳,获得10
23秒前
深情安青应助momo采纳,获得10
25秒前
25秒前
26秒前
可爱的函函应助hu采纳,获得10
28秒前
28秒前
29秒前
ABS发布了新的文献求助10
29秒前
30秒前
FashionBoy应助忘记时间采纳,获得30
31秒前
爆米花应助无情的匪采纳,获得10
32秒前
33秒前
刘寄奴发布了新的文献求助10
34秒前
su发布了新的文献求助10
36秒前
深情安青应助胡航航采纳,获得10
37秒前
小小发布了新的文献求助30
38秒前
CodeCraft应助苗条梦玉采纳,获得10
39秒前
jia完成签到 ,获得积分10
40秒前
43秒前
43秒前
44秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989297
求助须知:如何正确求助?哪些是违规求助? 3531418
关于积分的说明 11253893
捐赠科研通 3270097
什么是DOI,文献DOI怎么找? 1804884
邀请新用户注册赠送积分活动 882087
科研通“疑难数据库(出版商)”最低求助积分说明 809158